SCHEMBL2940506

SCHEMBL2940506

N#Cc1cccc(C(=O)N2CCC3(CC2)NC(Cc2ccccc2)C(=O)N3CC(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.40
USP2 O75604 3/20 0.40
CYP2D6 P10635 2/20 0.40
MGLL Q99685 1/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP2C19 P33261 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
NAMPT P43490 2/20 0.39
GAA P10253 1/20 0.39
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
GRM5 P41594 2/20 0.38
CCR3 P51677 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.37
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1803053 0.87 RIPK1 (0.44) CYP3A4USP2CYP2D6ALDH1A1CYP2C19
SCHEMBL2942520 0.84 CYP3A4 (0.58) CYP3A4USP2MGLLALDH1A1CYP2C19
SCHEMBL1796900 0.84 CYP3A4 (0.39) CYP3A4USP2CYP2D6MGLLALDH1A1
SCHEMBL2934834 0.84 NPC1 (0.48) USP2ALDH1A1GAATSHR
SCHEMBL2942653 0.83 HPGD (0.42) ALDH1A1GAATSHRKMT2A
SCHEMBL2941530 0.82 HPGD (0.43) ALDH1A1SMN1; SMN2MAPK1TSHRKMT2A
SCHEMBL2943001 0.81 MEN1 (0.39) CYP3A4CYP2D6MGLLCYP2C19GAA
SCHEMBL3997343 0.81 NAMPT (0.42) CYP3A4USP2CYP2D6MGLLALDH1A1
SCHEMBL2940005 0.81 MGLL (0.43) CYP3A4MGLLALDH1A1CYP2C19SMN1; SMN2
SCHEMBL2943558 0.79 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2CYP1A2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP claimed